David Auslander PhD

David Ausländer joined Novartis in 2017 as Principal Scientist of Cell Line Development. Before, he worked as research scientist at ETH Zürich with the focus on technology development for mammalian cell engineering and Synthetic Biology. He received his doctorate from ETH Zürich in 2014, where he developed synthetic gene circuits for mammalian cells with applications in biopharmaceutical manufacturing and cell-based therapies.